Advertisement

Sucralfate pp 333-337 | Cite as

Future Research into the Mechanisms of Action of Sucralfate

  • Daniel Hollander

Abstract

Sucralfate is a nonabsorbable, nonsystematic agent for the therapy and prevention of peptic ulcer disease. The drug was originally developed in Japan as an agent to deactivate peptic activity. Sucralfate was found to adhere to both ulcerated and normal mucosa with a preference for damaged areas of the gastric mucosa. 1 For these reasons, the original proposals to explain sucralfate’s therapeutic efficacy and its mechanisms of action included both pepsin antagonism and surface adhesion which presumably protect ulcerated areas from luminal acid, enzymes and exogenous damaging agents such as NSAIDs, or alcohol.

Keywords

Gastric Mucosa Lamina Propria Peptic Ulcer Disease Surface Epithelium Gastrointestinal Mucosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bighley L, Giesing D: Mechanism of action studies of sucralfate, in Caspary W (ed): Duodenal Ulcer. Gastric Ulcer: Sucralfale. a New Therapeutic Concept. Munich, Urban &0026; Schwarzenberg, 1981, pp 3–12. Early thoughts as to the mechanisms of action of sucralfate.Google Scholar
  2. 2.
    Hollander D, Tarnawski A, Gergely H, et al: Sucralfate protection of the gastric mucosa agalnst ethanol-induced injury: A prostaglandin-mediated process? Scan J Gastroenterol 19:97–102, 1984.Google Scholar
  3. 3.
    Hollander D, Tarnawski A, Krause WJ, et al: The protective effect of sucralfate agalnst alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural and functional time sequence analysis. Gastroenterology 88:366–374, 1985.PubMedGoogle Scholar
  4. 4.
    Tarnawski A, Hollander D, Krause WJ, et al: Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural and functional assessment. Gastroenterology 90:893–905, 1986.PubMedGoogle Scholar
  5. 5.
    Tarnawski A, Hollander D, Stachura J, et al: Effect of sucralfate on the normal human gastric mucosa. Endoscopic, histological and ultrastructural assessment. Scand J Gastroenterol 22:111–123, 1987. References 2–5 explored the mechanisms of sucralfate interaction with the normal and ulcerated gastric mucosa and sucralfate’s cytoprotective mechanisms.CrossRefGoogle Scholar
  6. 6.
    Tarnawski A, Hollander D, Stachura J, et al: Prostaglandin protection of the gastric mucosa agalnst alcohol injury, a dynamic time related process. The role of the mucosal proliferative zone. Gastroenterology 89:366–374, 1985.Google Scholar
  7. 7.
    Tarnawski A, Stachura J, Gergely H, et al: Microvascular endothelium—A major target for alcohol injury of the human gastric mucosa. Histochemical and ultrastructural study. J Clin Gastroenterol 10:53–64, 1988.CrossRefGoogle Scholar
  8. 8.
    Tarnawski A, Stachura J, Hollander D, et al: Cellular aspects of alcohol-induced injury and prostaglandin protection of the human gastric mucosa. Focus on the mucosal microvessels. J Clin Gastroenterol 10:35–45, 1988. References 6–8 represent some of the key experiments regarding the mechanisms of cytoprotective activity of prostaglandins.CrossRefGoogle Scholar
  9. 9.
    Hollander D, Tarnawski A: Gastric Cytoprotection: A Clinician’s Guide. New York, Plenum Press, 1989. A general review of the concept of cytoprotection, its mechanisms, and its clinical applications. This book is directed at both investigators and clinicians.Google Scholar
  10. 10.
    Szabo S, Brown A: Prevention of ethanol-induced vascular injury and gastric mucosal lesions by sucralfate and its components: Possible role of endogenous sulfhydryls. Proc Soc Exp Biol Med 185:493–497, 1987.PubMedGoogle Scholar
  11. 11.
    Szabo S, Hollander D: Pathways of gastrointestinal protection and repalr. Am J Med 86(6A):23–31, 1989.PubMedCrossRefGoogle Scholar
  12. 12.
    Konturek SJ, Brzozowski T, Bielanski W, et al: Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats. Am J Med 86(6A):32–37, 1989. References 10–12 add other mechanisms to the list of mechanisms of action of sucralfate.PubMedCrossRefGoogle Scholar
  13. 13.
    Hollander D: Permeability in Crohn’s disease: Altered barrier functions in healthy relatives? Gastroenterology 104:1848–1851, 1993. A review of the concept of intestinal permeability of larger molecules. Permeability of the gastrointestinal barrier by sucralfate could instigate immunological and reparative reactions in the subepithelial layers and explaln some of sucralfate’s clinical activity.PubMedGoogle Scholar
  14. 14.
    Hollander D: Integrins: A family of cell surface adhesion receptors—Relevance to intestinal immune defenses. Eur J Gastroenterol Hepatol 5:593–599, 1993. Review of cell surface adhesion molecules of the gastroduodenal mucosa.CrossRefGoogle Scholar
  15. 15.
    Thomson ABR:Helicobacter pylori and gastroduodenal pathology. Can J Gastroenterol 7:353–358, 1993. Recent review of the importance of H. pylori in ulcer disease.Google Scholar
  16. 16.
    Bianchi Porro G, Hollander D: Treatment of Digestive Disease with Sucralfate. New York, Raven Press, 1989. Review of the mechanisms of action of sucralfate with preliminary data on the possible activity of sucralfate in intestinal inflammation.Google Scholar

Copyright information

© Plenum Press 1995

Authors and Affiliations

  • Daniel Hollander
    • 1
  1. 1.Dean’s OfficeUniversity of Kansas School of MedicineKansas City

Personalised recommendations